Key result
Intravenous Isch-BMSCs given 24 hours after stroke in rats were superior to Nor-BMSCs in promoting functional outcome, angiogenesis, arterial density, and axonal regeneration.
Answers are grounded in this paper and cite their sources.
Demonstrates enhanced neurorestoration with stroke-derived bone marrow stromal cells in rat stroke models, suggesting autologous cellular therapy benefits.
BACKGROUND AND PURPOSE: We compared the effect of treatment of stroke with bone marrow stromal cells from stroke rats (Isch-BMSC) and normal rats (Nor-BMSC) on functional outcome. METHODS: Isch-BMSCs and Nor-BMSCs were intravenously injected into rats 24 hours after middle cerebral artery occlusion. To test the mechanism of Isch-BMSC-enhanced neurorestoration, Isch-BMSC and Nor-BMSC cultures were used. RESULTS: Isch-BMSC significantly promoted functional outcome and enhanced angiogenesis, arterial density, and axonal regeneration compared with Nor-BMSC treatment animals. Isch-BMSCs exhibited increased Angiopoietin-1, Tie2, basic fibroblast growth factor, glial cell-derived neurotrophic factor, vascular endothelial growth factor, and Flk1 gene expression compared with Nor-BMSC. Using transwell coculture of BMSCs with brain-derived endothelial cells, Isch-BMSCs increased phosphorylated-Tie2 activity in brain-derived endothelial cells and enhanced brain-derived endothelial cells capillary tube formation compared with Nor-BMSCs. Inhibition of Tie2 gene expression in brain-derived endothelial cells using siRNA significantly attenuated BMSC-induced capillary tube formation. CONCLUSIONS: These data suggest that Isch-BMSCs are superior to Nor-BMSCs for the neurorestorative treatment of stroke, which may be mediated by the enhanced trophic factor and angiogenic characteristics of Isch-BMSCs.
No takes yet. Share an insight, caveat, or question.
Zacharek et al. (2010) studied Stroke (middle cerebral artery occlusion in rats). Bone marrow stromal cells from stroke rats (Isch-BMSC) vs. Bone marrow stromal cells from normal rats (Nor-BMSC) was evaluated on Functional outcome, angiogenesis, arterial density, and axonal regeneration. Intravenous Isch-BMSCs given 24 hours after stroke in rats were superior to Nor-BMSCs in promoting functional outcome, angiogenesis, arterial density, and axonal regeneration.
Synapse has enriched 10 related papers. Consider them for comparative context: